These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10415874

  • 1. The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.
    Jones L, Ghaneh P, Humphreys M, Neoptolemos JP.
    Ann N Y Acad Sci; 1999 Jun 30; 880():288-307. PubMed ID: 10415874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stromal degradation by the malignant epithelium in pancreatic cancer and the therapeutic potential of proteolytic inhibition.
    Bramhall SR.
    J Hepatobiliary Pancreat Surg; 1998 Jun 30; 5(4):392-401. PubMed ID: 9931388
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinase inhibitors: applications in oncology.
    Yip D, Ahmad A, Karapetis CS, Hawkins CA, Harper PG.
    Invest New Drugs; 1999 Jun 30; 17(4):387-99. PubMed ID: 10759405
    [Abstract] [Full Text] [Related]

  • 7. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S, Cao J, Chen WT.
    Oncogene; 2000 Dec 27; 19(56):6642-50. PubMed ID: 11426650
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Marimastat (BB2516): current status of development.
    Steward WP.
    Cancer Chemother Pharmacol; 1999 Dec 27; 43 Suppl():S56-60. PubMed ID: 10357560
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG.
    Drugs Aging; 1997 Sep 27; 11(3):229-44. PubMed ID: 9303281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y.
    Carcinogenesis; 1999 Jul 27; 20(7):1323-9. PubMed ID: 10383907
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of matrix metalloproteinase inhibitors in cancer therapy.
    Hidalgo M, Eckhardt SG.
    J Natl Cancer Inst; 2001 Feb 07; 93(3):178-93. PubMed ID: 11158186
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.